Get the Stockscreener App
24.89
2.18%
0.53
Tg Therapeutics Inc stock is traded at $24.89, with a volume of 1.74M.
It is up +2.18% in the last 24 hours and up +11.97% over the past month.
See More
Previous Close:
$24.36
Open:
$24.49
24h Volume:
1.74M
Relative Volume:
0.50
Market Cap:
$3.40B
Revenue:
$346.73M
Net Income/Loss:
$95.69M
P/E Ratio:
-88.89
EPS:
-0.28
Net Cash Flow:
$67.82M
1W Performance:
-3.19%
1M Performance:
+11.97%
6M Performance:
+53.74%
1Y Performance:
+125.05%
1-Day Range:
$23.60
$24.93
1-Week Range:
$22.92
$26.99
52-Week Range:
$9.81
$26.99
Tg Therapeutics Inc Stock (TGTX) Company Profile
Name
Tg Therapeutics Inc
Sector
Industry
Phone
(212) 554-4484
Address
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-02-23 | Upgrade | Goldman | Sell → Neutral |
| Jun-26-23 | Resumed | Jefferies | Buy |
| May-20-22 | Initiated | BofA Securities | Underperform |
| Feb-23-22 | Reiterated | B. Riley Securities | Buy |
| Nov-15-21 | Downgrade | Goldman | Neutral → Sell |
| Apr-20-21 | Initiated | Goldman | Neutral |
| Apr-19-21 | Reiterated | H.C. Wainwright | Buy |
| Sep-01-20 | Initiated | JP Morgan | Overweight |
| Aug-11-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-05-20 | Initiated | Evercore ISI | Outperform |
| Jan-17-20 | Reiterated | H.C. Wainwright | Buy |
| Nov-27-19 | Resumed | B. Riley FBR | Buy |
| Feb-06-19 | Resumed | Jefferies | Buy |
| Sep-25-18 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-09-18 | Reiterated | B. Riley FBR, Inc. | Buy |
| Dec-01-17 | Resumed | B. Riley FBR, Inc. | Buy |
| Nov-14-17 | Resumed | H.C. Wainwright | Buy |
| Apr-25-17 | Initiated | Jefferies | Buy |
| Mar-06-17 | Reiterated | FBR & Co. | Outperform |
| Oct-06-16 | Resumed | Brean Capital | Buy |
| May-27-16 | Initiated | SunTrust | Buy |
| Dec-01-15 | Initiated | FBR Capital | Outperform |
| Sep-09-15 | Initiated | Raymond James | Strong Buy |
| Aug-12-15 | Resumed | H.C. Wainwright | Buy |
| Jun-19-15 | Reiterated | Brean Capital | Buy |
| Dec-11-14 | Reiterated | ROTH Capital | Buy |
| Dec-10-14 | Reiterated | ROTH Capital | Buy |
View All
Tg Therapeutics Inc Stock (TGTX) Latest News
TG Therapeutics (NASDAQ:TGTX) Given New $22.00 Price Target at The Goldman Sachs Group - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Posts Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Q3 2024 Earnings Call Transcript - Insider Monkey
TG Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Rec - GuruFocus.com
TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
Earnings call: TG Therapeutics reports robust growth for BRIUMVI - Investing.com
Earnings call: TG Therapeutics reports robust growth for BRIUMVI By Investing.com - Investing.com UK
TG Therapeutics Posts Strong Q3 Briumvi Revenue, Here’s Why Shares Fell - Seeking Alpha
TG Therapeutics (TGTX) Lags Q3 Earnings Estimates - MSN
(TGTX) Trading Advice - Stock Traders Daily
FUJIFILM Diosynth Biotechnologies To Manufacture TG Therapeutics' MS Drug - Contract Pharma
TG Therapeutics (NASDAQ:TGTX) Shares Gap DownHere's What Happened - MarketBeat
Morning Brew: Nvidia Joins Dow, Fed Rate Cut Looms, and TG Thera - GuruFocus.com
FUJIFILM Diosynth Biotechnologies Signs Manufacturing Supply Agreement with TG Therapeutics - GlobeNewswire
TG Therapeutics: Q3 Earnings Snapshot - The Washington Post
TG Therapeutics, Inc. (NASDAQ:TGTX) Stock Holdings Increased by Raymond James & Associates - Defense World
TG Therapeutics Reports Third Quarter 2024 Financial - GlobeNewswire
TG Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
State of Alaska Department of Revenue Makes New $1.78 Million Investment in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
TG Therapeutics (TGTX) Set to Announce Quarterly Earnings on Monday - MarketBeat
TG Therapeutics stock hits 52-week high of $26.46 By Investing.com - Investing.com Canada
TG Therapeutics (NASDAQ:TGTX) Hits New 1-Year HighShould You Buy? - MarketBeat
TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update - GlobeNewswire
TG Therapeutics stock hits 52-week high of $26.46 - Investing.com India
Louisiana State Employees Retirement System Buys New Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Is TG Therapeutics, Inc. (TGTX) Set to Explode in 2025? - Insider Monkey
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
10 Stocks Set to Explode in 2025 - Insider Monkey
Assenagon Asset Management S.A. Sells 318,709 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
TD Cowen Initiates Coverage of TG Therapeutics (TGTX) with Buy Recommendation - MSN
TG Therapeutics (NASDAQ:TGTX) Shares Gap UpStill a Buy? - MarketBeat
The Analyst Verdict: TG Therapeutics In The Eyes Of 5 Experts - Benzinga
TD Cowen Initiates Coverage on TG Therapeutics (NASDAQ:TGTX) - MarketBeat
Trading (TGTX) With Integrated Risk Controls - Stock Traders Daily
TG Therapeutics Inc (TGTX) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle
TG Therapeutics (NASDAQ:TGTX) Trading Up 4.9%What's Next? - MarketBeat
Director, Lonial Sagar sold 16,348 shares of TG Therapeutics Inc [TGTX] - Knox Daily
TG Therapeutics Inc (TGTX)’s stock performance: a year in review - US Post News
(TGTX) Trading Report - Stock Traders Daily
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class ActionTGTX - AsiaOne
TG Therapeutics Inc (TGTX) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
TGTX’s price-to-book ratio: An indicator of the company’s performance - US Post News
TG Therapeutics Inc (TGTX) is looking forward to a strong quarter - SETE News
TG Therapeutics, Inc. (NASDAQ:TGTX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Stake Cut by Millennium Management LLC - MarketBeat
Algert Global LLC Increases Stock Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Point72 Asset Management L.P. Makes New $10.42 Million Investment in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
These 5 Stocks Grew More than Bitcoin Over the Last Year - Investopedia
TG Therapeutics, Inc.'s (NASDAQ:TGTX) institutional investors lost 3.3% over the past week but have profited from longer-term gains - Simply Wall St
Tg Therapeutics Inc Stock (TGTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tg Therapeutics Inc Stock (TGTX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Lonial Sagar | Director |
Jun 17 '24 |
Sale |
16.39 |
9,585 |
157,098 |
99,293 |
| Lonial Sagar | Director |
Mar 13 '24 |
Sale |
15.94 |
5,000 |
79,675 |
108,878 |
| Charney Laurence N | Director |
Mar 12 '24 |
Sale |
15.97 |
22,000 |
351,340 |
215,229 |
| Charney Laurence N | Director |
Jan 05 '24 |
Sale |
19.03 |
17,500 |
333,025 |
237,229 |
| Power Sean A | CFO |
Jan 03 '24 |
Sale |
16.91 |
47,867 |
809,431 |
606,969 |
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):